Trial intelligence / Profile preview

EHSG-KF vs STSG for Full-Thickness Skin Defects

NCT03394612Phase 2Completed

Sponsor
CUTISS
Start
Feb 2018
Primary completion
Dec 2023
Countries
3
01

Overview

A Phase 2 trial of denovoSkin in skin wound, sponsored by CUTISS. Started Feb 2018; status: completed.

02

Drugs

denovoSkin
03

Conditions

skin wound

Beyond the preview

Go deeper on NCT03394612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03394612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call